細胞ベースアッセイの世界市場：細胞株、試薬、キット、装置、ソフトウェア、サービス...市場調査レポートについてご紹介

1 Introduction (Page No. – 9)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 12)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 19)

4 Premium Insights (Page No. – 26)
4.1 Lucrative Opportunities in the Cell-Based Assays Market
4.2 Life Cycle Analysis, By Region

5 Market Overview (Page No. – 30)
5.1 Introduction
5.1.1 By Product
5.1.2 By Application
5.1.3 By End User
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increase in R&D Investments
5.2.1.2 Government Funding and Public-Private Partnerships Supporting Cell-Based Research Activities
5.2.1.3 Advantages of Cell-Based Assay Over Prevalent Technologies
5.2.1.4 Drug Discovery, A Major Driver for the Cell-Based Assay Market
5.2.2 Restraints
5.2.2.1 High Instrument Costs
5.2.2.2 Stringent Regulatory Policies
5.2.2.3 Intellectual Property Rights Issues Restricting Innovations in the Market
5.2.3 Opportunities
5.2.3.1 Asian Region Offers High-Growth Opportunities
5.2.3.2 Developments in High-Content Screening and Software to Transform Cell-Based Screening
5.2.4 Trends
5.2.4.1 Label-Free Technologies are Set to Transform the Market

6 Cell-Based Assays Market, By Product (Page No. – 40)
6.1 Introduction
6.2 Consumables
6.2.1 Reagents & Assay Kits
6.2.1.1 Reporter Gene Assays
6.2.1.2 Second Messenger Assays
6.2.1.3 Cell Growth Assays
6.2.1.4 Cell Death Assays
6.2.1.5 Other Assays
6.2.2 Microplates
6.2.3 Cell Lines
6.2.3.1 Immortalized Cell Lines
6.2.3.2 Primary Cell Lines
6.2.3.3 Stem Cell Lines
6.2.4 Other Consumables
6.3 Instruments
6.4 Services
6.5 Software

7 Cell-Based Assays Market, By Application (Page No. – 61)
7.1 Introduction
7.2 Drug Discovery
7.3 Basic Research
7.4 Adme Studies
7.5 Predictive Toxicology
7.6 Other Applications

8 Cell-Based Assays Market, By End User (Page No. – 72)
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.3 Academic & Government Institutions
8.4 Contract Research Organizations
8.5 Other End Users

9 Cell-Based Assays Market, By Region (Page No. – 82)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.4 Asia
9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. – 122)
10.1 Introduction
10.2 Strategic Overview
10.3 Market Share Analysis
10.4 Competitive Situation and Trends
10.4.1 New Product Launches
10.4.2 Acquisitions
10.4.3 Collaborations and Agreements
10.4.4 Expansions
10.4.5 Other Developments

11 Company Profiles (Page No. – 129)
11.1 Introduction
11.2 Becton, Dickinson and Company
11.2.1 Business Overview
11.2.2 Products & Services Offered
11.2.3 Recent Developments
11.2.4 MnM View
11.2.4.1 Financial Analysis
11.2.4.2 Strategic Analysis
11.3 Cell Signaling Technology, Inc.
11.3.1 Business Overview
11.3.2 Products & Services Offered
11.3.3 Recent Developments
11.4 Cisbio Bioassays
11.4.1 Business Overview
11.4.2 Products Offered
11.4.3 Recent Developments
11.4.4 MnM View
11.4.4.1 Strategic Analysis
11.5 Danaher Corporation
11.5.1 Business Overview
11.5.2 Products Offered
11.5.3 Recent Developments
11.5.4 MnM View
11.5.4.1 Financial Analysis
11.5.4.2 Strategic Analysis
11.6 Discoverx Corporation
11.6.1 Business Overview
11.6.2 Products & Services Offered
11.6.3 Recent Developments
11.6.4 MnM View
11.6.4.1 Strategic Analysis
11.7 General Electric Company
11.7.1 Business Overview
11.7.2 Products Offered
11.7.3 Recent Developments
11.7.4 MnM View
11.7.4.1 Financial Analysis
11.7.4.2 Strategic Analysis
11.8 Merck & Co., Inc.
11.8.1 Business Overview
11.8.2 Products & Services Offered
11.8.3 Recent Developments
11.8.4 MnM View
11.8.4.1 Financial Analysis
11.9 Perkinelmer, Inc.
11.9.1 Business Overview
11.9.2 Products & Services Offered
11.9.3 Recent Developments
11.9.4 MnM View
11.9.4.1 Financial Analysis
11.9.4.2 Strategic Analysis
11.10 Promega Corporation
11.10.1 Business Overview
11.10.2 Products Offered
11.10.3 Recent Developments
11.10.4 MnM View
11.10.4.1 Strategic Analysis
11.11 Thermo Fisher Scientific, Inc.
11.11.1 Business Overview
11.11.2 Products Offered
11.11.3 Recent Developments
11.11.4 MnM View
11.11.4.1 Financial Analysis
11.11.4.2 Strategic Analysis

12 Appendix (Page No. – 164)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports